ARS Pharmaceuticals (SPRY) Assets (2020 - 2026)
ARS Pharmaceuticals (SPRY) reported Assets of $249.5 million for Q2 2026, down 20.4% from $313.47 million a year earlier and down 13.2% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, ARS Pharmaceuticals posted Assets of $327.65 million, down 6.7% from FY2024.
- Assets has a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- By year, Assets came in at $351.15 million in FY2024 (+50.6%), $233.19 million in FY2023 (-17.1%), $281.44 million in FY2022 (+358.0%) and $61.45 million in FY2021 (-84.4%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q3 2024.
- Year over year, Assets has now declined in each of the last three quarters, with growth averaging 19.4% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q4 2022 (growth of 358.0%); the low point was Q4 2021 (a decline of 84.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $287.57 million (Q1 2026), $327.65 million (Q4 2025) and $372.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn | 249.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 249.50 Mn |
| Mar 31, 2026 | 287.57 Mn |
| Dec 31, 2025 | 327.65 Mn |
| Sep 30, 2025 | 372.80 Mn |
| Jun 30, 2025 | 313.47 Mn |
| Mar 31, 2025 | 327.32 Mn |
| Dec 31, 2024 | 351.15 Mn |
| Sep 30, 2024 | 217.60 Mn |
| Jun 30, 2024 | 221.97 Mn |
| Mar 31, 2024 | 227.58 Mn |
| Dec 31, 2023 | 233.19 Mn |
| Sep 30, 2023 | 248.56 Mn |
| Jun 30, 2023 | 258.75 Mn |
| Mar 31, 2023 | 271.19 Mn |
| Dec 31, 2022 | 281.44 Mn |
| Sep 30, 2022 | 271.06 Mn |
| Jun 30, 2022 | 294.00 Mn |
| Mar 31, 2022 | 312.47 Mn |
| Dec 31, 2021 | 61.45 Mn |
| Sep 30, 2021 | 352.56 Mn |
API Access
ARS Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();